Patent directory · USPTO A61K / A61P
Patents matching “anti-pd-”
25 pharma patents match "anti-pd-" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 25 pharmaceutical patents matching "anti-pd-" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
WO 2026107143
COMBINAISON DE DOSES FIXES D'ANTICORPS ANTI-FUCOSYL-GM1 ET D'ANTICORPS ANTI-PD-1 ET SES UTILISATIONS
granted -
WO 2026057739
POLYTHÉRAPIE COMPRENANT DES ANTICORPS ANTI-CTLA4 ET DES ANTICORPS ANTI-PD-1 POUR LE TRAITEMENT DU CANCER DE L'OVAIRE RÉSISTANT AU PLATINE
granted -
US 12427173
Use of bacteria, bacterial products, and other immunoregulatory entities in combination with anti-CTLA-4 and/or anti-PD-1 antibodies to treat solid tumor malignancies
granted -
US 12338269
IL-2 superagonists in combination with anti-PD-1 antibodies
granted -
TW 202515903
Anti-PD-1-based treatment before and after surgery
granted -
WO 2025040080
TRAITEMENT DU CANCER DE L'OESOPHAGE PAR ANTI-LAG3, ANTI-PD-1 ET CHIMIOTHÉRAPIE
granted -
US 12054557
Combination of anti-PD-1 antibodies and bispecific anti-CD20/anti-CD3 antibodies to treat cancer
granted -
US 12054556
Anti-PD-L1 antibody and use thereof
granted -
US 12053534
Radiolabeled anti-PD-L1 antibodies for immuno-PET imaging
granted -
US 11993655
Anti-PD-L1 antibody and use thereof
granted -
US 11926668
Anti-PD-1 antibodies for treatment of lung cancer
granted -
CA 3245150
COMBINAISONS AVEC UN ANTICORPS ANTI-CD39 HUMAIN, UN ANTICORPS ANTI-PD-1 HUMAIN ET UNE CHIMIOTHÉRAPIE CONTRE LE CANCER GASTRIQUE
granted -
US 11566076
Anti-CSF1R antibody and anti-PD-1 antibody combination therapy for selected cancers
granted -
US 11542312
IL-2 superagonists in combination with anti-PD-1 antibodies
granted -
US 11421034
Combination anti-CSF1R and anti-PD-1 antibody combination therapy for pancreatic cancer
granted -
US 11324822
Combination of HDAC inhibitor and anti-PD-1 antibody for treatment of cancer
granted -
US 11292842
Anti-PD-1 antibodies for treatment of lung cancer
granted -
US 11254752
Methods for treating cancer with bispecific anti-CD3xMUC16 antibodies and anti-PD-1 antibodies
granted -
US 11254746
Anti-PD-1 monoclonal antibody, and preparation method therefor and application thereof
granted -
US 10822414
Anti-PD-1 antibodies, compositions comprising anti-PD-1 antibodies and methods of using anti-PD-1 antibodies
granted -
US 10786552
Il-2Rβ-selective agonists in combination with an anti-CTLA-4 antibody or an anti-PD-1 antibody
granted -
US 10744116
Detection and treatment of anti-PD-1 therapy resistant metastatic melanomas
granted -
US 10736976
Radiolabeled anti-PD-L1 antibodies for immuno-PET imaging
granted -
US 10683347
Treatment of cancer using anti-TGF-β and anti-PD-1 antibodies
granted